The Indian Venture Capital Journal is a unique single point of resource for pertinent information in the VC/PE space and intends to provide a forum to share and debate issues relating to it. This second issue is a continued effort to present in-depth quality research and analysis of various sectors pertaining to the VC/PE space in India providing a plug in the gaping hole of information in this stratum.

In this issue, the editors have chosen to explore the evolution of the LifeSciences industry in India , and what this means for PE funding. With the lowering of trade barriers and becoming TRIPS compliant in 2005, this sector is now on the fast-forward mode, making rapid strides on many fronts. IVCJ examines recent landmark transctions and explores new opportunities for private equity and venture capital players in the Pharmaceutical, Biotech and Healthcare segments.